Nasser H. Hanna, MD, discusses challenges in consolation immunotherapy for patients with lung cancer.
Nasser H. Hanna, MD
Advertisement
Articles by Nasser H. Hanna, MD
Advertisement
Latest Updated Articles
Dr. Hanna on Challenges With Consolidation Immunotherapy in Lung CancerPublished: November 10th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5